{"name":"Commissariat A L'energie Atomique","slug":"commissariat-a-l-energie-atomique","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"3. Reversibility test with salbutamol","genericName":"3. Reversibility test with salbutamol","slug":"3-reversibility-test-with-salbutamol","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"3. Reversibility test with salbutamol","genericName":"3. Reversibility test with salbutamol","slug":"3-reversibility-test-with-salbutamol","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPbDZtNGgyWlZBRUxLOE9VMVh0TFA5UjJJSkl5TXRnX0JXb3BXWVZJYk5VSEZrVklGMEtLUUVYeTJMcVFQeUZLS25yRUxiczNYTEhiMmUwQVQyakg3VUYybUw5bVAxOVo5WHNiVWxVYm5ZWTVRTWxfNWFtTzlBZzdRa2xjTkNrUDlQUDRBaERicTdjZ0wxQmh5cnVxa2JsV3N1UUNDUUY5cE9MQkljZ25VNW5QT3ZHRHdjUkdBSnhtczEwbzJzWklmZGZPcVAtNE15Z1BuaGo2UWtGU1M2VlNoNnhoSFJQTEl4YTYzTGJ0UXdwV1NFUy0tWVVwU24zWmhqSlB4YWtZUWhfbGNNemVJ?oc=5","date":"2020-03-02","type":"pipeline","source":"usc.gal","summary":"The TRANS-INT project brings important advances in the use of nanotechnology for the development of new oral therapies, with relevance for the treatment of diabetes, obesity and other pathologies - us","headline":"The TRANS-INT project brings important advances in the use of nanotechnology for the development of new oral therapies, ","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}